Hannes H.

Hannes H. is a seasoned professional in the life sciences and technology sectors, currently serving as the Director of Life Science Investments & Data Science at Thiel Capital since 2018. Hannes is also a member of the Board of Directors for multiple innovative companies, including Ataraxis AI, Peptilogics, Blackrock Neurotech, and Immunochina Pharmaceuticals, contributing to advancements in cancer treatment, biotechnology, and neurotechnology. Previous roles include positions as a Biomedical Informatics Scientist at Knight Lab, Senior Adviser at GWC Inc, Entrepreneur In Residence at Ironfire Ventures, and Data Science Fellow at Social Capital LP. Hannes holds a Bachelor of Science in Computer Science with honors from UC San Diego and a Bilingual International Abitur Diploma from German Swiss International School.